Bayer Repinotan Development Slowed By Dosing Issue, FDA Documents Show

Bayer will use a loading dose of the stroke drug repinotan in Phase III trials following discussions with FDA over how best to maximize treatment response, agency documents show

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet